X @Bloomberg
Drug Development - AstraZeneca's experimental hypertension drug Baxdrostat reduced blood pressure in patients with uncontrolled or treatment-resistant hypertension [1]
Drug Development - AstraZeneca's experimental hypertension drug Baxdrostat reduced blood pressure in patients with uncontrolled or treatment-resistant hypertension [1]